Orphenadrine Citrate Drug Classification
Orphenadrine citrate is a centrally acting skeletal muscle relaxant with anticholinergic properties. 1
Primary Drug Class
- Centrally acting skeletal muscle relaxant - This is the primary therapeutic classification of orphenadrine citrate 1
- The medication does not act directly on skeletal muscle tissue itself, but rather works through central nervous system mechanisms 1
- It is structurally similar to diphenhydramine (an antihistamine), which explains some of its pharmacological properties 1
Secondary Pharmacological Properties
- Anticholinergic agent - Orphenadrine possesses significant anticholinergic actions that contribute to both its therapeutic effects and adverse effect profile 1, 2
- Analgesic properties - The mode of therapeutic action may be related to its analgesic properties, though the precise mechanism has not been clearly identified 2
- NMDA receptor antagonist - Orphenadrine acts as an uncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist, which may contribute to its analgesic effects 3
Clinical Context
- Orphenadrine is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions 2
- The medication is available in both oral and intravenous formulations 1
- It is commonly administered both preoperatively and perioperatively in surgical settings 1
Important Caveat
While orphenadrine is classified as a skeletal muscle relaxant, its precise mechanism of action remains unclear, and it does not directly relax tense muscles in humans 2. The therapeutic benefit likely derives from a combination of its anticholinergic properties, NMDA receptor antagonism, and analgesic effects rather than true muscle relaxation 2, 3.